Traditional global pharma partner deal and details should beavailable in January, 2024. The FDA site approval license that LABS has expires at the end of this month and continuation of that site approval will merely be done under the wing with our publicly announced partner. In case you were wondering how Pidduck could pull forward the 2024 LTIP portion and announce it in late December 2023.
I've could have merely said 'the deal is done' but it doesn't have much meaning and appreciation until you understand how the pieces moved and why.
And so too to those that persevered, Happy New Year!